Clinical Trial Update: Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing three botulinum neuromodulators for managing facial synkinesis after facial nerve injury; study completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Asymmetry
• Facial Nerve Injury
• Facial Paresis
• Facial Synkinesis

Drugs mentioned

• Botox (OnabotulinumtoxinA)
• Dysport (abobotulinumtoxinA)
• XEOMIN (INCOBOTULINUMTOXINA)

Snippet

Sponsor: University of Utah | Conditions: Facial Nerve Injuries, Facial Paresis Associated With Facial Nerve Dysfunction | Phase 4 | Status: COMPLETED | Results posted: 2017-07-31